Fingerprint
Dive into the research topics of 'Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer
Alexandra Canonici, Merel Gijsen, Maeve Mullooly, Ruth Bennett, Noujoude Bouguern, Kasper Pedersen, Neil A O'Brien, Ioannis Roxanis, Ji-Liang Li, Esther Bridge, Richard Finn, Dennis Siamon, Patricia McGowan, Michael J Duffy, Norma O'Donovan, John Crown, Anthony Kong
Research output: Contribution to journal › Article › peer-review
105
Citations
(Scopus)